From MASK-air and SILAM to CATALYSE (Climate Action To Advance HeaLthY Societies in Europe)
Bernardo Sousa‐Pinto, Yuliia Palamarchuk, Lucas Leemann, S Jankin, Xavier Basagaña, Joan Ballester, Anna Bedbrook, W Czarlewski, Rute Almeida, Tari Haahtela, Hanna Haveri, M Prass, Teresa Henriques, Rafael José Vieira, Ludger Klimek, Markus Ollert, Mohamed H. Shamji, Marek Jutel, Stefano Del Giacco, Maria J. Torres, Torsten Zuberbier, João Fonseca, Mikhail Sofiev, J. M. Antó, Jean Bousquet
Abstract
Plant species vary under different climatic conditions and the distribution of pollen in the air. Trends in pollen distribution can be used to assess the impact of climate change on public health. In 2015, the Mobile Airways Sentinel networK for rhinitis and asthma (MASK-air®) was launched as a project of the European Innovation Partnership on Active and Healthy Ageing (EIP-on-AHA, DG Santé and DG CONNECT). This project aimed to develop a warning system to inform patients about the onset of the pollen season, namely, the System for Integrated modeLling of Atmospheric coMposition (SILAM). A global-to-meso-scale dispersion model was developed by the Finnish Meteorological Institute (FMI). It provides quantitative information on atmospheric pollution of anthropogenic and natural origins, particularly on allergenic pollens. Impact of Air Pollution on Asthma and Rhinitis (POLLAR, EIT Health) has combined MASK-air clinical data with SILAM forecasts. A new Horizon Europe grant (Climate Action to Advance HeaLthY Societies in Europe [CATALYSE]; grant agreement number 101057131), which came into force in September 2022, aims to improve our understanding of climate change and help us find ways to counteractit. One objective of this project is to develop early warning systems and predictive models to improve the effectiveness of strategies for adapting to climate change. One of the warning systems is focused on allergic rhinitis (CATALYSE Task 3.2), with a collaboration between the FMI (Finland), Porto University (Portugal), MASK-air SAS (France), ISGlobal (Spain), Hertie School (Germany), and the University of Zurich (Switzerland). It is to be implemented with the support of the European Academy of Allergy and Clinical Immunology. This paper reports the planning of CATALYSE Task 3.2.